SFDCT / Dow Settlement Disease Criteria

Atypical Connective Tissue Disease (ACTD), Atypical Rheumatic Syndrome (ARS)
& Non-Specific Autoimmune Condition (NAC) - page 2
Do I Have A Case?
Expedited Release Checks Important Please Read
The Settlement Facility Dow Corning Trust has recently decided to send Expedited Release Payments ($2,000) to all claimants whose cases are idle.
The Dow Settlement criteria states that if you accept this payment you can NEVER apply for a disease claim in the future, even if you become sick.
If you receive one of these checks in the mail, please do not cash it until you speak with an attorney to discuss your potential claim.
Again, if you cash this check you have effectively settled your claim and can never get any additional money.
SFDCT Medical Criteria
Learn about the medical criteria that you will need to meet in order to submit a disease claim through the SFDCT Settlement.
Changes in texture or rashes that may or may not be characteristic of SLE, Systemic Sclerosis (scleroderma), or dermatomyositis.
Diffuse petechiae, telangiectasias, or livedo reticularis.
Loss of sensation to pinprick, vibration, touch, or position
Tingling, paresthesia or burning pain in the extremities
Loss of tendon reflex
Proximal or distal muscle weakness (loss of muscle strength in extremities or weakness of ankles, hands, or foot drop)
Signs of dysesthesia
Entrapment neuropathies
Group II Signs and Symptoms:
B.
Myalgias determined by tenderness on examination

Immune mediated skin changes or rash as follows:
Pulmonary symptoms or abnormalities, which may or may not be characteristic of SLE, Systemic Sclerosis (scleroderma), or Sjogren's Syndrome, as follows:
Pleural and/or interstitial lung disease
Restrictive lung disease
Obstructive lung disease as evidenced by characteristic clinical findings and either:
1.
Characteristic chest X-ray changes or
2.
Characteristic pulmonary function test abnormalities in a non-smoker (e.g. decreased DLCO or abnormal arterial blood gases)
Pericarditis defined by consistent clinical findings and either EKG or echocardiogram

Neuropsychiatric symptoms: cognitive dysfunction (memory loss and/or difficulty concentrating) which may be characteristic of SLE or MCTD as determined by a SPECT scan or PET scan or MRI or EEG or neuropsychological testing

Peripheral neuropathy diagnosed by physical examination showing one (1) or more of the following:
Myositis or myopathy:
Diagnosed by weakness on physical examination or by muscle strength testing
Abnormal CPK or aldolase
Abnormal cybex testing
Abnormal EMG
Abnormal muscle biopsy
[Page 1][Page 2][Page 3]
727-397-9198 9am-5pm / Mon.-Thu.